Cargando…
Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment?
Recently, preclinical and clinical studies targeting several types of cancer strongly supported the key role of the gut microbiota in the modulation of host response to anti-tumoral therapies such as chemotherapy, immunotherapy, radiotherapy and even surgery. Intestinal microbiome has been shown to...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770123/ https://www.ncbi.nlm.nih.gov/pubmed/31533218 http://dx.doi.org/10.3390/ijms20184584 |